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AP-1 . ' Lee et al. 1987; Chiu et al. 1988 . ' Halazonetis et al. 1988; Nakabeppu et al. 1988; Rauscher et al. 1988a, b; Sassone-Corsi et al. 1988a ; for review, see Curran and Franza 1988} . However, not all Fos/lun complexes behave in a similar way with regard to the regulation of AP-l-dependent transcription. While a c-Fos/ c-lun complex is a transcriptional activator {Chiu et al. 1988 . ' Lucibello et al. 1988 .' Sassone-Corsi et al. 1988a Sch6nthal et al. 1988) , lunB acts as a repressor (Schfitte et al. 1989) . In addition to a role in the control of AP-1-dependent gene expression, the c-Fos protein has transrepressing functions that are independent of DNA binding, including the repression of the c-los promoter {Sassone- Corsi et al. 1988b; K6nig et al. 1989; Lucibello et al. 1989} and of glucocorticoid receptor-dependent transcription (lonat et al. 1990 . ' Lucibello et al. 1990} .
The [osB gene was identified by screening a cDNA library of serum-induced genes with an oligonucleotide representing the conserved DNA-binding site in Fos {Ze-rial et al. 1989) . Sequence analysis of the isolated cDNA revealed an open reading frame of 338 amino acids, encompassing the known structural features of Fos proteins, that is, a basic domain involved in DNA binding and a leucine zipper as the dimerization interface (Kouzarides and Ziff 1988; Gentz et al. 1989; Neuberg et al. 1989; Schuermann et al. 1989; Turner and Tjian 1989) . The formation of FosB/Jun complexes and their interaction with the AP-1 site [also referred to as TPA responsive element (TRE)] was shown in in vitro complex reconstitution and gel-retardation assays (Zerial et al. 1989) . These analyses also suggested that FosB and c-Fos proteins do not differ in the properties investigated. The only known functional difference between the two proteins is the recently reported repression of the glucocorticoid receptor by c-Fos/v-Fos but not by FosB (Lucibello et al. 1990 ).
The deregulation of c-fos expression suffices to induce morphological transformation in rodent fibroblast cell lines Meijlink et al. 1985) . Structural alterations in the protein, as they occur in v-Fos, enhance the transforming properties and can activate the immortalizing potential (Jenuwein and Miiller 1987) . The mechanism by which transformation is brought about remains, however, largely obscure. Although an intact leucine zipper, a functional DNA-binding site and the ability to trans-activate AP-l-dependent transcription are prerequisites for transformation, they are not sufficient Lucibello et al. 1991; Neuberg et al. 1991 ) . Even less is known about the mechanisms involved in FosB-induced transformation, which is partly due to the fact that FosB is poorly characterized in molecular terms.
Here, we report that the fosB transcript is subject to alternative splicing. Two mRNA forms are consecutively expressed following serum stimulation and show antagonistic properties with respect to transformation and trans-repression. Of particular interest is the observation that only the long form of FosB is able to transform fibroblasts efficiently and to trans-repress, and that both of these functions are counteracted by the short form. Our results point to a new regulatory mechanism governing the trans-regulation of gene expression by Fos family members and suggest that different trans-regulatory functions are involved in the transformation by different members of the Fos family.
R e s u l t s

Two forms of fosB mRNA are induced by serum stimulation
In the course of experiments dealing with the delineation of exon-intron boundaries in the mouse fosB gene, we obtained results that were not compatible with the published sequence of a fosB cDNA (Zerial et al. 1989) . A closer inspection of the nucleotide sequence revealed the presence of potential splice donor (SD; AG/GTGAGA) and splice acceptor (SA; CAG) sites in fosB transcripts (see Fig. la ), which might result in the expression of an alternative mRNA. To test this hypothesis we synthesized a set of primers (5'p and 3'p in Fig. la ) to amplify cDNAs (Saiki et al. 1988) The two fosB mRNA forms are derived from a single gene To verify that the two m R N A forms are generated by alternative splicing of a single primary transcript rather than by transcription of two fosB genes, we performed Southern blot analyses of mouse genomic D N A and compared the observed pattern with the restriction map established for the kfosB phage described above (Fig. 3 ).
Mouse liver D N A was digested with BamHI, XhoI, or SacI, and the blot was hybridized to a c D N A probe covering the entire coding region, as indicated in Figure 3a . The observed number of hybridizing fragments (two for SacI and BamHI; one for XhoI), as well as their sizes (10.0 and 1.8 kb for SacI; 4.8 and 3.0 kb for BamHI; -1 4 kb for XhoI), is in perfect agreement with that of the isolated phage, demonstrating that all fragments were derived from a single gene. This result therefore supports the Alternative [osB splicing conclusion that fosB-L and fosB-S are generated by alternative splicing. We also sought to confirm the presence of two alternatively spliced RNAs by nuclease S 1 mapping. A probe covering the splice junction in fosB-S was generated by isolating a genomic BamHI-SphI fosB fragment. This probe should give rise to a fragment of 884 bp protected by fosB-L mRNA and a fragment of 590 bp protected by fosB-S mRNA (see Fig. 4a ). Fragments of these sites were indeed detected when RNA from stimulated NIH-3T3 cells was analyzed in a nuclease S 1 protection assay ( Fig.  4b ; 3T3-S), using two different enzyme concentrations (200 and 400 units). In contrast, no protected fragments were observed with RNA from unstimulated cells (3T3-Q), underscoring the specificity of the results.
Differential expression of fosB-L and fosB-S after serum stimulation
We investigated the temporal expression of the two fosB mRNA forms after serum stimulation. Serum-deprived NIH-3T3 cells were stimulated with 10% FCS, and RNA was isolated for 0, 15, 30, 60, 90, and 120 min poststimulation, transcribed into cDNAs, and amplified by polymerase chain reaction (PCR) (Saiki et al. 1988 ). The PCR conditions were established such that amplification of the cDNAs was linearly dependent on the concentration of the corresponding mRNAs. This was achieved by performing the reactions in the presence of [a-32p] dCTP, so that owing to the greater sensitivity of autoradiography as opposed to ethidium bromide staining, a relatively low number of PCR cycles was sufficient to detect the amplified products. In this way, the cDNA concentration remained the rate-limiting factor throughout the amplification procedure (D. Mumberg et al., unpubl.).
For control purposes, the RNA was also analyzed by Northern blotting using a fosB cDNA as the probe. Figure 5a shows that the expression of fosB mRNA in our experiment followed the known kinetics, and hybridization to a GAPDH probe indicates that equal amounts of intact RNA were used for each time point. The PCR analysis in Figure 5b revealed a clearly differential expression of both fosB mRNA forms. Although fosB-L showed maximum expression at 15-30 rain, fosB-S appeared later, peaking -6 0 min poststimulation. In contrast, ~-actin, which was included as a control, showed no significant variation in the level of expression. These experiments were performed three times with independently isolated RNA samples, and fosB-L mRNA clearly preceded the shorter form each time (data not shown). Serum stimulation was also performed in the presence of the protein synthesis inhibitor cycloheximide (CHX) to analyze whether expression of FosB-L protein is necessary for the synthesis of fosB-S mRNA (Fig. 5b ). This does not seem to be the case, because the short RNA form appeared also in the presence of CHX and even seemed to be expressed at higher levels than fosB-L. As expected, mRNA degradation was largely prevented by CHX, leading to a stable induction of both fosB-L and fosB-S during the period analyzed in the present experiment.
Construction of fosB genes encoding specific protein forms
The differential expression of fosB-L and fosB-S raised the intriguing possibility that the short form might encode a protein that counteracts the preceding action of the longer counterpart. According to this hypothesis, The m u t a n t proteins were then inserted into a eukaryotic expression vector containing the SV40 early promoter. To be able to specifically identify m R N A s expressed from these plasmids (after transcription into c D N A and PCR-mediated amplification) we also introduced new restriction sites into constructs pFosB-L and pFosB-S, together w i t h the m u t a t i o n s described above. Digestion of PCR products from cell lines stably transfected with these plasmids could thus be carried out to verify that the expected exogenous fosB mRNA forms were expressed. Two fosB-L-expressing clones (L1, L2) and two fosB-S-expressing cell lines (S1, $2) showed the expected 322-bp fragment, which could be digested with either XbaI (L1, L2) or BglII (S1, $2) to yield two bands of 138/184 and 141/181 bp, respectively (see Fig. 6a and b) . Untransfected 208F cells showed a much weaker signal, presumably representing the endogenous fosB mRNA, which is probably also responsible for the weak upper band ("uncut" position) seen in the digested samples.
Expression of FosB-L and FosB-S proteins
The clones of fosB-L-and fosB-S-expressing cells described above were then analyzed for the synthesis of the respective FosB proteins. Cells were metabolically pulselabeled with [3SS]methionine, lysed in R1PA buffer, treated with SDS to disrupt FosB/Jun complexes, and lmmunoprecipitated with a FosB-specific antibody raised against the amino-terminal 14 amino acids (kindly provided by Dr. J. Adamkiewicz, IMT). Figure 7 shows that pFosB-L and pFosB-S cells expressed proteins of -4 5 and 35 kD, respectively, which comigrated with FosB-L and FosB-S synthesized by in vitro transcription-translation. Similarly sized proteins were also detected in serumstimulated NIH-3T3 cells. Precipitation of the 35-and 45-kD proteins was completely abolished by competiAlternative fosB splicing tion with the specific peptide (used as the hapten for immunization) but not by an unrelated peptide. We therefore conclude that (1) the two endogenous mRNA forms in NIH-3T3 cells are translated into protein, and (2) the constructed plasmids express the expected proteins, corresponding to the endogenous products generated by alternative splicing. Interestingly, transfection of pFosB, which contains an intact SD site, leads to the expression of only FosB-L. This suggests that the alternative splicing mechanism functions only in the context of the primary transcript.
TRE binding of FosB-L/Jun and FosB-S/lun complexes
To analyze the DNA-binding properties of the two FosB forms we reconstituted FosB-L/c-Jun and FosB-S/c-Jun complexes from the respective in vitro-translated proteins and analyzed these complexes for binding to an oligonucleotide containing the collagenase TRE. The results of the gel-retardation analysis are shown in Figure  8 . As expected, the uncomplexed proteins did not show any significant binding under the conditions of the assay (lanes 1-3), whereas both forms of FosB gave clear shifts at room temperature (lanes 4 and 5) and at 37°C (lanes 6 and 7). The observed binding was specific, as it was competed by a 100-fold excess of the specific TRE oligonucleotide but not by a similar amount of a random oligonucleotide. These results show that both FosB-L and FosB-S are able to bind to the TRE in complexes with c-Jun. Cold
Trans-regulation by FosB-L and FosB-S
We then tested the trans-activating potential of the FosB-L and FosB-S proteins. Figure 9 shows that in HeLa cells both proteins were able to trans-activate expression of a 5x TRE-chloramphenicol acetyltransferase (CAT) reporter construct (10-and 7-fold, respectively), similar to pFosB (5-fold). Likewise, the coexpression of pFosB-L and pFosB-S resulted in a five-to sevenfold induction of CAT activity. As controls, two v-Fos expression plasmids were included. Expression of E300 resulted in an 18-fold trans-activation, and an E300 protein with an impaired leucine zipper (L3-4-5; Schuermann et al. 1989) only led to an insignificant increase in CAT activity (twofold). These results indicate that both FosB forms are able to trans-activate the 5 x T R E -C A T construct. Practically identical results were obtained with NIH-3T3 cells as the recipients (data not shown).
To analyze the trans-repression potential of pFosB-L and pFosB-S we tested their effect on a c-fos-promoter/ CAT construct in serum-stimulated cells, as described for c-Fos trans-repression (Lucibello et al. 1989 ). Figure   10 shows that both pFosB and pFosB-L were able to trans-repress the c-fos-CAT reporter construct by ~65%, whereas pFosB-S was unable to do so. Interestingly, the repression by pFosB-L was suppressed by coexpressed pFosB-S (right-most lane), indicating that the right-most lane) with a defective leucine zipper due to the mutation of 3 leucines ); (vector) the empty expression vector pMSE (Schuermann 1990 ).
short FosB form is not only incapable of trans-repression but also acts as an antagonist.
Transforming potential of pFosB-L and pFosB-S
Finally, we analyzed the transforming properties of the two FosB forms in a focus assay using 208F cells as the recipients. The results displayed in Table 1 clearly show that only the long FosB form was able to induce significant numbers of foci: While pFosB and pFosB-L induced 74 and 69 foci, respectively, only 5 and 9 foci were seen with the empty expression vector pMSE and pFosB-S, respectively. It cannot be decided at this point whether the transforming potential of pFosB-S is very low or not existent at all, due to the formation of a low number of spontaneous foci in the vector control plates. The reason for the latter is the relatively long time needed for fosBinduced loci to become macroscopically visible (>3 weeks). The focus assay was also performed with NIH-3T3 cells with very similar results (data not shown). The very low or absent transforming potential of pFosB-S was not due to a toxic effect, as similar numbers of G418 R 208F colonies could be obtained with all constructs (335 colonies/~g of pFosB; 287 colonies/~g of pFosB-L; 330 colonies/~g of pFosB-S), and stable lines expressing FosB-S could also be obtained (see experiments shown in Figs. 6b and 7) . This result is important in view of the the ability of FosB-S to suppress transformation by pFosB-L: Cotransfection of 1 ~g of pFosB-L and 1, 2, or 3 ~g of empty vector DNA yielded between 70 and 112 foci; cotransfer of 1 ~g of pFosB-L and 1, 2, or 3 ~g of pFosB-S gave only 15-20 foci. This observation clearly suggests that pFosB-S does not only lack significant transforming properties but also possesses antioncogenic properties with respect to pFosB-L-induced transformation.
Discussion
Induction of the fosB gene is part of the immediate early response of cells after stimulation with growth factors (Zerial et al. 1989) . A cDNA clone representing a fosB mRNA has been isolated and shown to contain the known structural elements of bZip proteins, that is, a leucine zipper flanked by a basic region representing part of a bipartite DNA-binding domain. Considering the high homology of this region with the c-Fos-bZip domain it was not surprising to find that both proteins show very similar, if not identical, DNA-binding properties in a complex with a Jun protein. In this study we have identified a second fosB mRNA generated by alternative splicing, whose encoded product (FosB-S) lacks the 101 carboxy-terminal amino acids present in the longer FosB-L protein. This truncation leaves the leucine zipper and the adjacent basic region intact, which is reflected by the ability of both FosB-L and FosB-S proteins to bind cooperatively with c-Jun to TRE. The two fosB mRNA forms are differentially expressed following serum stimulation, the long form preceding the short form by -30 min. This observation deserves particular attention in view of the fact that the two forms of FosB differ in their transforming and trans-repressing properties: Only FosB-L is able to repress a c-los-promoter~CAT reporter construct, and FosB-S can suppress the trans-repressing effect of FosB-L. Likewise, only the long form induces transformation efficiently, and this function is also antagonized by FosB-S. These functional differences suggest that the trans-regulatory action of FosB-L, activated upon serum stimulation, is counteracted by the subsequently expressed FosB-S. The consecutive expression of an oncogenic trans-regulator and anti-oncogenic antagonist derived from the same gene represents a novel Alternative fosB splicing mechanism regulating the action of Fos family members.
The fact that FosB-S is unable to repress the c-los-promoter construct suggests that a region in the 101 aminoacid carboxy-terminal stretch of FosB-L is required for trans-repression. The carboxyl terminus of FosB-L, which is not well conserved among Fos and FosB, contains a conspicuous cluster of 7 contiguous proline residues followed by another stretch rich in prolines and serines, which might play a role in this type of transregulation by FosB-L. It has been shown that proline-rich domains are involved in transcriptional activation by other proteins (Mitchell and Tjian 1989) and thus represent potential interfaces for protein-protein interactions. However, at least in the cell systems analyzed in the present study (NIH-3T3 fibroblasts and HeLa cells), this region does not seem to be crucial for the other trans-regulatory function of FosB-L, trans-activation of AP-l-dependent transcription, because FosB-S was at least as efficient at activating the 5 x TRE-CAT reporter construct as FosB-L.
It is conceivable that the cell has devised additively acting regulatory mechanisms that keep the potentially oncogenic action of Fos proteins under constraint. It has already been shown that transcriptional activation occurs only at a precise time and only for several minutes following growth factor stimulation (Greenberg and Ziff 1984; Kruijer et al. 1984; Mfiller et al. 1984) , the synthesized mRNA is degraded rapidly with a half-life of -10 min , and Fos proteins turn over with short half-lives of 30-120 min M~iller et al. 1984) . In addition, trans-repression by Fos protein has been shown to be dependent on the phosphorylation status of the protein (Ofir et al. 1990 ). The data reported in this discussion suggest that another mechanism can be added to this list, the counteraction of a specific function exerted by FosB-L, that is, its transrepressing properties, by another product of the same gene generated by differential splicing.
Our results show clearly that FosB-L is an oncoprotein and that the shorter form of FosB possesses only very weak, if any, transforming properties. This is not due to a toxic effect exerted by FosB-S, as all FosB constructs were able to induce similar numbers of G418 R colonies. The transforming potential of the FosB constructs does not seem to correlate with their trans-activating potential, because FosB-S does not transform efficiently despite its trans-activating properties. A much better correlation seems to exist between transformation and trans-repression, both of which are efficiently mediated only by FosB-L and suppressed by FosB-S. This observation is particularly interesting in view of the fact that a similar correlation is not found for the induction of transformation by v-Fos and trans-repression (Lucibello et al. 1989 ). This raises the intriguing possibility that different members of the Fos family use different molecular mechanisms to induce transformation in fibroblasts.
Negative regulation of trans-regulatory proteins by interacting factors has been described in other instances, such as the E-box-binding factors MyoD, El2, and E47, Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genesdev.cshlp.org Downloaded from whose interaction with DNA is negatively affected by complex formation with the Id protein (Benezra et al. 1990 ). Likewise, differential splicing of proto-oncogene transcripts is not a novel feature of fosB. It has been shown that alternative splicing is responsible for the tissue-specific expression of c-abl (Beh-Neria et al. 1986; Bernards et al. 1988 ) and c-src (Levy et al. 1987; mRNAs; and the c-H-ras transcript is subject to differential splicing, although the significance of the shorter form remains obscure (Cohen et al. 1989b ). Another interesting example is the alternative splicing of c-myb transcripts, which generates a truncated protein, termed Mbm2, in addition to the full-length product cMyb (Weber et al. 1990 ). Although c-Myb blocks the dimethylsulfoxide (DMSO)-induced differentiation of mouse erythroleukemia cells, the shorter Mbm2 protein, which lacks the transcriptional regulatory regions, enhances their differentiation (Weber et al. 1990 ).
These observations suggest that proteins acting at crucial points in proliferation and differentiation-controlling pathways are not only regulated at the level of expression but also by modulation of their activity through post-translational modifications and interaction with other factors. Such multiple regulatory mechanisms might ensure the proper functioning of biological processes that involve the rapid switching between different functional states of the regulatory "master" proteins, as it occurs in the induction of cell division and differentiation by growth factors or hormones. In addition, perturbations in such regulatory networks due to mutations or abnormal environmental situations would not necessarily cause havoc, because other mechanisms might still be able to keep the physiological balance.
Another study reporting alternative splicing of fosB transcripts has been published (Nakabeppu et al. 1991) . Both that study and this one are in agreement with regard to the structure of the alternatively spliced RNAs and the behavior of their products in trans-repression. In contrast to our findings, Nakabeppu et al. report that FosB-S is unable to trans-activate TRE-dependent transcription and can block trans-activation by FosB-L. The other aspects addressed in our study, that is, kinetics of expression and transforming properties of the two FosB forms, were not analyzed by Nakabeppu et al. (1991) . Two major differences in the experimental conditions may account for the apparent discrepancy in the transactivation study. Nakabeppu et al. used F9 teratocarcinoma stem cells, which are known to differ from NIH-3T3 and HeLa cells in that they contain basically no endogenous AP-1 activity (Chiu et al. 1988) . It is conceivable that the availability of endogenous factors acting on AP-1 sites may have a significant influence on the results of the assay. In addition, different reporter constructs were used in the two studies, containing either a single TRE (Nakabeppu et al. 1991) or five copies of the TRE (this study). It is possible that FosB-S shows transactivation properties only with oligomerized binding sites. Further experiments will have to establish the role of cell type and target sequence specificity in FosB-mediated trans-activation.
Materials and methods
Cell culture
F9, HeLa, 208F, and 3T3 cells were cultured in Dulbecco-Vogt modified Eagle minimum essential medium (DMEM) supplemented with 10% fetal calf serum (FCS), 0.5% glucose, penicilin (100 U/ml), and streptomycin (100 mg/ml). Serum-deprived cells were kept for 20 hr in serum-free DMEM and stimulated with 10% FCS. In some experiments, CHX was added 1 hr before serum stimulation.
Northern blot analysis
RNA was prepared according to Chirgwin et al. (1979) , and Northern blot analysis was performed as described previously (Thomas 1980; Miiller et al. 1983) .
PCR and analysis of PCR products
For cDNA synthesis 1 cg of total RNA was annealed to 1 ~g of oligo(dT) and incubated with 200 units of Moloney murine leukemia virus reverse transcriptase for 1 hr at 37°C in a final volume of 20 ¢1. One-tenth of the reaction mixture was amplified by 25 cycles of PCR (Saiki et al. 1988) 
Cloning and analysis of the fosB-S PCR fragment
The PCR-amplified 322 bp containing the fosB-S splice junction fragment was purified by agarose-gel electrophoresis, digested with RsaI and Hinfl, and blunt-end-ligated in a pTZ18R vector. DNA sequencing was carried out according to Chen and Seeburg (1985) using the Sequenase version 2.0 DNA sequencing kit {U.S. Biochemical).
Nuclease S1 protection analysis
Nuclease S1 protection analysis was performed essentially as described in Hagen et al. {1990) . A genomic SphI fragment was end-labeled with [~/-3Zp]ATP and digested with BamHI, and the resulting BamHI-SphI fragment was isolated by agarose-gel electrophoresis. This probe (2 x 105 cpm) was hybridized overnight at 59°C to 30 ~g of total RNA from quiescent cells or from cells stimulated with 10% FCS for 1 hr. Nuclease S1 digestions were carried out for 1 hr at 37°C.
In vitro transcription-translation
The in vitro transcription-translation of FosB-S, FosB-L, and Jun proteins was performed as described in Schuermann et al. (1989) .
Gel retardation analysis
Binding reactions were performed by incubating 5 ~1 of FosB-S or FosB-L and 5 ~1 of Jun-containing in vitro translation mixtures with 1.5 ~g/ml poly[d(I-C)] in a buffer containing 10 mM HEPES (pH 7.9), 60 mM KCI, 4% Ficoll, 1 mM EDTA, and 1 mM dithiothreitol for 60 min on ice. Approximately 2.5 x 10 4 cpm of labeled double-stranded oligonucleotide containing an AP-1-binding site was added, and incubation was continued for an- other 60 min at either room temperature or 37°C. The reaction mixtures were separated on 4% polyacrylamide gels at 10 V/cm (Barberis et al. 1987) .
Imm unopr ecipi t ati ons
208F cells transfected with pFosB, pFosB-S, pFosB-L, or empty expression vector were selected in G418-containing medium, as described above, and grown to confluency. Prior to labeling with [3SS]methionine, the cells were kept in serum-free medium for 18 hr. Metabolic labeling and the subsequent preparation of lysates were performed according to Jenuwein and Miiller (1987) . To disrupt protein complexes (e.g., Fos/Jun), aliquots of lysate were heated at 95°C for 5 min in the presence of 0.5% SDS, cooled down to room temperature, and diluted with RIPA buffer without SDS to give a final SDS concentration of 0.1%. Eight microliters of rabbit polyclonal anti-peptide antiserum, raised against a FosB peptide spanning the amino-terminal 14 amino acids of the FosB protein (kindly provided by Dr. J. Adamkiewicz), was added to 100 ~1 of cleared lysate and incubated on ice for 2-3 hr, followed by the addition of 60 ~1 of protein ASepharose and incubation for 60 min on ice. Washing of immune complexes, gel electrophoresis, and subsequent processing of the gels were performed as described in Schuermann et al. (1989) .
PCR-mediated mutagenesis
The PCR protocols described above were also used to introduce site-specific mutations in the cloned fosB cDNA. Two pairs of oligonucleotides were designed, one to change codon 238 (valine) into a stop codon (TGA), and a second one to destroy the splice donor site following codon 237 (glutamic acid). In addition, two primers, located -200 bp in either direction from the mutation site, were chosen. All primers also contained suitable restriction sites, which allowed subsequent directional cloning and new internal sites to facilitate their identification (BglII and XbaI). Numbers in Table 2 indicate nucleotide positions according to Zerial et al. (1989) .
FosB-S1 and FosB-L1 oligonucleotides were combined with primer FosB-N to amplify 197 bp of fosB cDNA fragments. FosB-$2 and FosB-L2 in combination with primer FosB-P yielded fragments of 219 bp. All cDNA fragments obtained were digested with EcoRI and HindIII and cloned into pTZ 18R. The resulting clones were sequenced to verify the presence of the mutations and the correct reading frame. The subcloned FosB-S fragments were then fused via their BglII sites, and the subcloned FosB-L fragments were ligated via their XbaI sites. This step was followed by the addition of 3' FosB cDNA sequences inserted as a HincII (partial digest)-HindIII fragment. The resulting fosB genes, which were still missing the amino termini, were excised with PstI to replace the 1.1-kb PstI carboxy-terminal part of the original pTZfosB cDNA clone. Finally, the reconstituted fosB-S and fosB-L genes were excised with SstI and XhoI, ligated to BamHI linkers, and cloned into pMSE under the control of the SV40 early promoter (Schuermann 1990 ).
Focus assay
208F or NIH-3T3 cells (4 x 105) were transfected 24 hr after plating with plasmid DNA purified on CsC1 gradients plus NIH-3T3 carrier DNA to give a total amount of 10 ~tg of DNA per transfection. In the case of 208F cells, the medium was withdrawn after 4 hr, and the cells were washed twice with phosphate-buffered saline (PBS). Twenty-four hours after transfection, the cultures were split in a 1 : 3 ratio. The medium was changed every 3-4 days. Foci of morphologically altered cells were counted after 22-25 days. The formation of G418 a colonies was also determined by transfecting 1 ~g of plasmid DNA plus 5 ~g of NIH-3T3 carrier DNA and growing the transfected cells in selective medium containing 0.7 mg of G418/ml as described in Jenuwein et al. (1985) .
CA T assays
Transfections were essentially carried out according to Lucibello et al. (1988) . After trypsinization, 4 x 10 s HeLa or 1 x l0 s NIH-3T3 cells were seeded per 3-cm plate and transfected 24 hr later. Following transfection, 2.5 ~g of the reporter plasmid [5 x TREtkcat3 for trans-activation and the c-fos-CAT plasmid pA6CAT3 (Lucibello et al. 1989) for trans-repression] was coprecipitated with a total of 2.5 ~g of expression vector and empty vector DNA, as indicated in the legends to Figures 7 and 8. The DNA precipitate was left on the cells overnight. In transactivation assays, cells were then washed twice with PBS and incubated with DMEM plus 10% FCS for 24 hr. For serum stimulation, 10% FCS was added to the NIH-3T3 cells 36 hr after transfer to serum-free medium. Cells were lysed in situ in 125 ~1 of lysis buffer, and 10-50 ~tt was used to determine CAT activity, as described by Gorman et al. (1982) . Thin-layer chromatography plates were evaluated using a Packard beta imaging scanner. Protein concentrations were determined with a commercial assay kit (Bio-Rad), and activities were corrected accordingly. In some experiments, the transfection efficiency was monitored by cotransfection of a Rous sarcoma virus (RSV}-lacZ construct and determination of J3-galactosidase activity.
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